Pfizer COVID-19 vaccine: Why the US behind UK in approval - Business Insider

  • 📰 BusinessInsider
  • ⏱ Reading Time:
  • 29 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 15%
  • Publisher: 51%

United States News News

The UK has approved Pfizer and BioNTech's COVID-19 vaccine, but the US is still waiting. Here's why.

The MHRA reviewed data from the laboratory pre-clinical studies, clinical trials, manufacturing and quality controls, product sampling, and testing of the final vaccine,. The agency also considered the conditions for its safe supply and distribution.

Until January 1, 2021, the UK still has to follow EU rules, so vaccines in the UK would usually have to be approved by the Amsterdam-based European Medicines Agency . In the past, the agency has worked closely with UK regulator the Medicines and Healthcare Products Regulatory Agency . The EMA has said it hopes to authorize at least one vaccine by the end of the year. Pfizer said Tuesday it had asked the EU to approve its vaccine, and the EMA said its scientific committee will decide whether Pfizer's vaccine is safe and effective enough on or before December 29.

 

Thank you for your comment. Your comment will be published after being reviewed.
Please try again later.
We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

 /  🏆 729. in US

United States United States Latest News, United States United States Headlines